{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:51:03Z","timestamp":1789429863303,"version":"build-2803163510"},"reference-count":100,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Singapore NMRC CS-IRG","award":["MOH-001478-01"],"award-info":[{"award-number":["MOH-001478-01"]}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Early and accurate diagnosis of Parkinson\u2019s disease (PD) remains challenging in routine practice, as cardinal motor symptoms emerge only after substantial neurodegeneration has occurred. Blood-based biomarkers are therefore of considerable interest for identifying prodromal disease, enabling biologically stratified clinical trials, and supporting longitudinal monitoring. Among candidate markers, \u03b1-synuclein (\u03b1-Syn) is centrally relevant due to its fundamental role in PD pathogenesis. However, its peripheral measurement is complicated by marked molecular heterogeneity, uneven compartmental distribution, and analytical variability. In this narrative review, we examine the current evidence on blood-based \u03b1-Syn biomarkers with a focus on molecular diversity, compartmental biology, analytical platforms, and mechanisms governing central-peripheral exchange. We critically compare plasma, erythrocytes, and extracellular vesicle-based measurements and discuss the diagnostic implications of total, oligomeric, phosphorylated, and seeding-competent species. Recent advances in immunoassays, ultrasensitive technologies, mass spectrometry, and seed amplification assays (SAA) are also reviewed. Current evidence suggests that blood-based \u03b1-Syn assays hold promise, but their interpretation remains constrained by hemolysis, compartment-specific biology, assay heterogeneity, and limited longitudinal validation. Critically, no single blood-based \u03b1-Syn assay currently meets the performance standards required for standalone clinical application. Future progress will depend on methodological harmonization, multi-center and multi-ethnic studies, and integration with complementary biomarkers. A mechanistically grounded understanding of peripheral \u03b1-Syn dynamics is essential for developing clinically useful biomarker strategies for PD.<\/jats:p>","DOI":"10.3390\/ijms27146254","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:12:53Z","timestamp":1784023973000},"page":"6254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood-Based \u03b1-Synuclein Biomarkers in Parkinson\u2019s Disease: Molecular Diversity, Analytical Advances and Clinical Translation"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8163-0246","authenticated-orcid":false,"given":"Kailiang","family":"Ti","sequence":"first","affiliation":[{"name":"Department of Neurology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Pathology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng King","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Neuroscience Institute, Singapore 308433, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-1660","authenticated-orcid":false,"given":"Dongrui","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical Progression in Parkinson\u2019s Disease and the Neurobiology of Axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ana.27190","article-title":"Validating the Accuracy of Parkinson\u2019s Disease Clinical Diagnosis: A UK Brain Bank Case-Control Study","volume":"97","author":"Pecoraro","year":"2025","journal-title":"Ann. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: The SynNeurGe research diagnostic criteria","volume":"23","author":"Adler","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: A cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_8","first-page":"111","article-title":"Consensus guidelines for lumbar puncture in patients with neurological diseases","volume":"8","author":"Engelborghs","year":"2017","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Arias-Carri\u00f3n, O., Guerra-Crespo, M., Padilla-God\u00ednez, F.J., Soto-Rojas, L.O., and Manjarrez, E. (2025). \u03b1-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202504.2181.v1"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15227","DOI":"10.1523\/JNEUROSCI.3545-12.2012","article-title":"Systematic Mutagenesis of \u03b1-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities","volume":"32","author":"Sharma","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct Observation of the Interconversion of Normal and Toxic Forms of \u03b1-Synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson\u2019s disease: Molecules implicated in the formation and degradation of \u03b1-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/NEN.0b013e3186fc995","article-title":"Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of \u03b1-Synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","article-title":"Serine-129 phosphorylation of alpha-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function","volume":"111","author":"Madhivanan","year":"2023","journal-title":"Neuron"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18914","DOI":"10.1074\/jbc.RA118.005603","article-title":"Physiological C-terminal truncation of \u03b1-synuclein potentiates the prion-like formation of pathological inclusions","volume":"293","author":"Sorrentino","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41531-025-01084-y","article-title":"Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation","volume":"11","author":"Burtscher","year":"2025","journal-title":"npj Parkinsons Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jnc.14713","article-title":"Antibodies against alpha-synuclein: Tools and therapies","volume":"150","author":"Vaikath","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Nonaka","year":"2013","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18675","DOI":"10.1074\/jbc.M116.734707","article-title":"The Effect of Fragmented Pathogenic \u03b1-Synuclein Seeds on Prion-like Propagation","volume":"291","author":"Tarutani","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-025-00469-6","article-title":"Refining \u03b1-synuclein seed amplification assays to distinguish Parkinson\u2019s disease from multiple system atrophy","volume":"14","author":"Wiseman","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10072-019-03738-1","article-title":"Plasma alpha-synuclein levels in patients with Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"40","author":"Bougea","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","article-title":"Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: A meta-analysis","volume":"99","author":"Zubelzu","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000506480","article-title":"A Comparative Study of the Diagnostic Potential of Plasma and Erythrocytic \u03b1-Synuclein in Parkinson\u2019s Disease","volume":"19","author":"Wang","year":"2020","journal-title":"Neurodegener. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"Salem","year":"2006","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","article-title":"Plasma \u03b1-synuclein is decreased in subjects with Parkinson\u2019s disease","volume":"204","author":"Li","year":"2007","journal-title":"Exp. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","article-title":"The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy","volume":"113","author":"Lee","year":"2006","journal-title":"J. Neural Transm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.22928","article-title":"Plasma \u03b1-synuclein in patients with Parkinson\u2019s disease with and without treatment","volume":"25","author":"Duran","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3988\/jcn.2011.7.4.215","article-title":"Elevated Levels of \u03b1-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Na\u00efve Patients with Parkinson\u2019s Disease","volume":"7","author":"Park","year":"2011","journal-title":"J. Clin. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00702-013-0972-6","article-title":"Gender differences in Parkinson\u2019s disease: Focus on plasma alpha-synuclein","volume":"120","author":"Caranci","year":"2013","journal-title":"J. Neural Transm."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chang, C.-W., Yang, S.-Y., Yang, C.-C., Chang, C.-W., and Wu, Y.-R. (2020). Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients with Parkinson\u2019s Disease. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.01388"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10072-016-2485-1","article-title":"A comparative study of the amount of \u03b1-synuclein in ischemic stroke and Parkinson\u2019s disease","volume":"37","author":"Zhao","year":"2016","journal-title":"Neurol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00702-016-1650-2","article-title":"Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson\u2019s disease","volume":"124","author":"Ding","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/jnnp-2016-314857","article-title":"Plasma \u03b1-synuclein predicts cognitive decline in Parkinson\u2019s disease","volume":"88","author":"Lin","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic \u03b1-Synuclein as a potential biomarker for Parkinson\u2019s disease","volume":"8","author":"Tian","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"623977","DOI":"10.3389\/fnagi.2021.623977","article-title":"Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson\u2019s Disease","volume":"13","author":"Li","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2022.09.011","article-title":"Erythrocytic alpha-synucleinin early Parkinson\u2019s disease: A 3-year longitudinal study","volume":"104","author":"Liu","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yu, Z., Liu, G., Zheng, Y., Gao, L., Li, X.-Y., and Feng, T. (2022). Erythrocytic \u03b1-Synuclein Species for Parkinson\u2019s Disease Diagnosis and the Correlations with Clinical Characteristics. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.827493"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107321","DOI":"10.1016\/j.parkreldis.2025.107321","article-title":"Aggregated \u03b1-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson\u2019s Disease","volume":"133","author":"Dimoula","year":"2025","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative Damage Linked to Neurodegeneration by Selective \u03b1-Synuclein Nitration in Synucleinopathy Lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kiechle, M., Grozdanov, V., and Danzer, K.M. (2020). The Role of Lipids in the Initiation of \u03b1-Synuclein Misfolding. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.562241"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","article-title":"Detection of \u03b1-synuclein oligomers in red blood cells as a potential biomarker of Parkinson\u2019s disease","volume":"599","author":"Wang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1096\/fj.10-179192","article-title":"Phosphorylated \u03b1-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u2019s disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-015-0185-3","article-title":"Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease: Correlation depends on disease severity","volume":"3","author":"Stewart","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"135274","DOI":"10.1016\/j.neulet.2020.135274","article-title":"Hemoglobin-\u03b1-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs","volume":"736","author":"Yang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Daniele, S., Frosini, D., Pietrobono, D., Petrozzi, L., Lo Gerfo, A., Baldacci, F., Fabbri, L., Siciliano, G., Bonuccelli, U., and Baldini, E. (2018). \u03b1-Synuclein Heterocomplexes with \u03b2-Amyloid Are Increased in Red Blood Cells of Parkinson\u2019s Disease Patients and Correlate with Disease Severity. Front. Mol. Neurosci., 11.","DOI":"10.3389\/fnmol.2018.00053"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2017.11.012","article-title":"Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson\u2019s Disease","volume":"672","author":"Papagiannakis","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1074\/mcp.M300132-MCP200","article-title":"The Human Erythrocyte Proteome: Analysis by Ion Trap Mass Spectrometry","volume":"3","author":"Kakhniashvili","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41592-021-01174-8","article-title":"L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma","volume":"18","author":"Norman","year":"2021","journal-title":"Nat. Methods"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1007\/s12035-025-04909-2","article-title":"Most L1CAM Is not Associated with Extracellular Vesicles in Human Biofluids and iPSC-Derived Neurons","volume":"62","author":"Kadam","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s13760-023-02452-2","article-title":"Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson\u2019s disease: A meta-analysis","volume":"124","author":"Shu","year":"2024","journal-title":"Acta Neurol. Belg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","article-title":"Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies","volume":"29","author":"Okuzumi","year":"2023","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JPD-230390","article-title":"Association of Misfolded \u03b1-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson\u2019s Disease Diagnosis and Duration","volume":"14","author":"Schaeffer","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/mds.29766","article-title":"Detecting Misfolded \u03b1-Synuclein in Blood Years before the Diagnosis of Parkinson\u2019s Disease","volume":"39","author":"Kluge","year":"2024","journal-title":"Mov. Disord."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Zougman","year":"2009","journal-title":"Nat. Methods"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Danko, K., Lukasheva, E., Zhukov, V.A., Zgoda, V., and Frolov, A. (2022). Detergent-Assisted Protein Digestion\u2014On the Way to Avoid the Key Bottleneck of Shotgun Bottom-Up Proteomics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213903"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nmeth0308-211","article-title":"Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking","volume":"5","author":"Atarashi","year":"2008","journal-title":"Nat. Methods"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pmic.200300677","article-title":"Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry","volume":"4","author":"Chertov","year":"2004","journal-title":"Proteomics"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12936-020-03225-5","article-title":"Comparison of ELISA with electro-chemiluminescence technology for the qualitative and quantitative assessment of serological responses to vaccination","volume":"19","author":"Bolton","year":"2020","journal-title":"Malar. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40035-024-00449-2","article-title":"\u03b1-Synuclein seeding amplification assays for diagnosing synucleinopathies: An innovative tool in clinical implementation","volume":"13","author":"Kuang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/acn3.729","article-title":"Plasma alpha-synuclein detected by single molecule array is increased in PD","volume":"6","author":"Ng","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35245","DOI":"10.1074\/jbc.M603964200","article-title":"Ultra-efficient Replication of Infectious Prions by Automated Protein Misfolding Cyclic Amplification","volume":"281","author":"Castilla","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"eadt7195","DOI":"10.1126\/sciadv.adt7195","article-title":"Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical use","volume":"11","author":"Lashuel","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.parkreldis.2023.105807","article-title":"\u03b1-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders","volume":"117","author":"Farris","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Rissardo, J.P., and Fornari Caprara, A.L. (2025). Alpha-Synuclein Seed Amplification Assays in Parkinson\u2019s Disease: A Systematic Review and Network Meta-Analysis. Clin. Pract., 15.","DOI":"10.3390\/clinpract15060107"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40035-025-00488-3","article-title":"Enhanced serum-based seed amplification assay for detecting propagative \u03b1-synuclein seeds in Parkinson\u2019s disease","volume":"14","author":"Kuang","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"ref_73","first-page":"e210279","article-title":"\u03b1-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal","volume":"104","author":"Coughlin","year":"2025","journal-title":"Parkinson Dis. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e70284","DOI":"10.1002\/alz.70284","article-title":"Alzheimer\u2019s disease traits in Parkinson\u2019s disease without alpha-synuclein seeding","volume":"21","author":"Farris","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1021\/acs.jpcb.2c08326","article-title":"Quantitative Seed Amplification Assay: A Proof-of-Principle Study","volume":"127","author":"Vaneyck","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1073\/pnas.1821409116","article-title":"\u03b1-synuclein\u2013lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson\u2019s disease patients","volume":"116","author":"Paslawski","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-023-00613-8","article-title":"Cerebrospinal fluid lipoproteins inhibit \u03b1-synuclein aggregation by interacting with oligomeric species in seed amplification assays","volume":"18","author":"Bellomo","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform\u2013specific disruption of amyloid \u03b2 peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-017-0470-4","article-title":"Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: Another mechanism for initiation and progression of Parkinson\u2019s disease?","volume":"5","author":"Matsumoto","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"105765","DOI":"10.1016\/j.parkreldis.2023.105765","article-title":"Elevated ApoE, ApoJ and lipoprotein-bound alpha-synuclein levels in cerebrospinal fluid from Parkinson\u2019s disease patients\u2014Validation in the BioFIND cohort","volume":"116","author":"Paslawski","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-021-01136-3","article-title":"Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson\u2019s disease","volume":"9","author":"Reyes","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1194\/jlr.M049429","article-title":"A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression","volume":"55","author":"Singh","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","article-title":"LRP1 is a neuronal receptor for \u03b1-synuclein uptake and spread","volume":"17","author":"Chen","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"100370","DOI":"10.1016\/j.jbc.2021.100370","article-title":"Hepatic LDL receptor-related protein-1 deficiency alters mitochondrial dynamics through phosphatidylinositol 4,5-bisphosphate reduction","volume":"296","author":"Chinnarasu","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41467-026-68641-8","article-title":"C1q-dependent clearance of alpha-synuclein allows macrophages to transiently limit enteric synucleinopathy in male mice","volume":"17","author":"Mackie","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2025.07.004","article-title":"Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson\u2019s disease patients independently of APOE","volume":"155","author":"Mascioli","year":"2025","journal-title":"Neurobiol. Aging"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1073858410381532","article-title":"Sink Hypothesis and Therapeutic Strategies for Attenuating A\u03b2 Levels","volume":"17","author":"Zhang","year":"2011","journal-title":"Neuroscientist"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/17582024.2025.2554531","article-title":"Serum Neurofilament light chain predicts autonomic symptoms in early Parkinson\u2019s disease","volume":"15","author":"Li","year":"2025","journal-title":"Neurodegener. Dis. Manag."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Chen, J.-H., Chan, L., Chung, C.-C., Bamodu, O.A., and Hong, C.-T. (2021). Blood Neurofilament Light Chain in Parkinson\u2019s Disease: Comparability between Parkinson\u2019s Progression Markers Initiative (PPMI) and Asian Cohorts. J. Clin. Med., 10.","DOI":"10.3390\/jcm10215085"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorders","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL discriminates Parkinson disease from atypical parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Global prevalence of Parkinson\u2019s disease","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of Cinpanemab in Early Parkinson\u2019s Disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnagi.2018.00051","article-title":"Promising metabolite profiles in the plasma and CSF of early clinical Parkinson\u2019s disease","volume":"10","author":"Stoessel","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Cristiani, C.M., Bovenzi, R., Pieri, M., Di Pietro, G., Malizia, A., Schirinzi, T., Di Lazzaro, V., Mercuri, N.B., Stefani, A., and Pisani, A. (2024). Erythrocytic \u03b1-synuclein in Parkinson\u2019s disease and progressive supranuclear palsy. Biomedicines, 12.","DOI":"10.3390\/biomedicines12112510"},{"key":"ref_99","first-page":"2","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/ejn.16290","article-title":"How close are we to a breakthrough? The hunt for blood biomarkers in Parkinson\u2019s disease diagnosis","volume":"59","author":"Liu","year":"2024","journal-title":"Eur. J. Neurosci."}],"updated-by":[{"DOI":"10.3390\/ijms27188177","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000}}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:20:36Z","timestamp":1789381236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":100,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146254"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146254","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}